Evidence map›Paper›PMID 19773194›Full record

ArticleParkinsonism & related disorders2010

Histamine N-methyltransferase Thr105Ile is not associated with Parkinson's disease or essential tremor.

Brett H Keeling, Carles Vilariño-Güell, Alexandra I Soto-Ortolaza, Owen A Ross, Ryan J Uitti, Alex Rajput, Zbigniew K Wszolek, Matthew J Farrer

Open access · greenAbstract read
In one paragraph

Article in Parkinsonism & related disorders, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Genomic Markers for Essential Tremor.Pharmaceuticals (Basel, Switzerland) · 2021
    Review
  6. Association Analyses ofNeuropsychiatric disease and treatment · 2021
    Article
  7. Genetic Risk Factors for Essential Tremor: A Review.Tremor and other hyperkinetic movements (New York, N.Y.) · 2020
    Review
  8. HistamineInternational journal of molecular sciences · 2019
    Review
  9. Article
  10. Article
  11. Key issues in essential tremor genetics research: Where are we now and how can we move forward?Tremor and other hyperkinetic movements (New York, N.Y.) · 2013
    Article
  12. Histamine: an undercover agent in multiple rare diseases?Journal of cellular and molecular medicine · 2012
    Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Brett H KeelingDepartment of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA.
Carles Vilariño-Güell
Alexandra I Soto-Ortolaza
Owen A Ross
Ryan J Uitti
Alex Rajput
Zbigniew K Wszolek
Matthew J Farrer
Mayo Clinic in Florida · USJacksonville College · USUniversity of Saskatchewan · CA

Funding

TRANSGENIC MODELING OF TAUOPATHYP01AG017216 · NIA · MAYO CLINIC JACKSONVILLE · PI DICKSON, DENNIS WILLIAM · 1999 to 2011
$12.0M
Genetics and Molecular Biology of ParkinsonismP50NS040256 · NINDS · MAYO CLINIC JACKSONVILLE · PI DICKSON, DENNIS WILLIAM · 2004 to 2009
$8.9M
MORRIS K. UDALL PARKINSONS DISEASE RESEARCH CENTER OF EXP01NS040256 · NINDS · MAYO CLINIC COLL OF MED, JACKSONVILLE · PI DICKSON, DENNIS WILLIAM · 1999 to 2003
$5.2M
Biomarkers for Preclinical Parkinson's diseaseR01NS057567 · NINDS · UNIVERSITY OF WASHINGTON · PI ZHANG, JING · 2008 to 2012
$3.1M
NEUROPSYCHOLOGY OF DEMENTIA WITH LEWY BODIESR01AG015866 · NIA · MAYO CLINIC JACKSONVILLE · PI FERMAN, TANIS JILL · 1999 to 2009
$2.6M
CIHR 121849NIA NIH HHS P01 AG017216NIA NIH HHS R01 AG015866NINDS NIH HHS P01 NS040256NINDS NIH HHS P50 NS040256NINDS NIH HHS P50 NS40256NINDS NIH HHS R01 NS057567
6 · The paper itself

Abstract

A functional variant in the Histamine N-Methyltransferase gene (HNMT - rs11558538) resulting in a threonine to isoleucine substitution (Thr105Ile) has been shown to impair histamine degradation. Two recent studies reported that the threonine allele of this polymorphism might be a risk factor for Parkinson disease (PD) and essential tremor (ET) development. Although PD and ET are considered different entities, they share some clinical and pathological features, suggesting a possible joint etiology. In this study we assess the role of the Thr105Ile variant in PD and ET development, genotyping the variant in a North American Caucasian PD and ET case-control series. Statistical analysis did not identify any significant association between this variant and PD or ET; therefore, our findings do not support the HNMT Thr105Ile variant as a factor in disease development or a genetic link between the disorders.

Indexed as

AdultAgedAged, 80 and overEssential TremorFemaleGene FrequencyGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHistamine N-MethyltransferaseHumansIsoleucineMaleMiddle AgedParkinson DiseasePolymorphism, GeneticHistamine N-MethyltransferaseIsoleucineThreonine

Identifiers

PMID19773194
PMCPMC2845175
OpenAlexW1986316543

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.